Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer
Clinical trial NCT04744831 · COMPLETED
Trial details
- NCT number
- NCT04744831
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-05
- Primary completion
- 2022-11-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.